ChatGPT 4o:
If an effective treatment were available that could repigment the skin of vitiligo patients, it is highly likely that many individuals would seek it and be willing to invest significant money into it. This assumption is supported by several key factors and statistical evidence.
Firstly, vitiligo significantly impacts mental health, with many patients experiencing psychological issues such as depression, anxiety, and low self-esteem. These challenges often drive individuals to seek treatments to improve their quality of life and reduce the emotional burden associated with the condition [oai_citation:1,Study reveals the economic burden for patients with vitiligo in the US is significant](https://medicalxpress.com/news/2024-01-reveals-economic-burden-patients-vitiligo.html) [oai_citation:2,Patient Burden of Nonsegmental Vitiligo: A US Real-World Survey of Dermatologists and Their Patients | Dermatology and Therapy](https://link.springer.com/article/10.1007/s13555-024-01165-5).
Financially, the economic burden on patients with vitiligo is already substantial. A study revealed that patients with vitiligo incur significantly higher all-cause and vitiligo-related healthcare costs compared to those without the condition. This includes higher costs related to mental health services, indicating a strong demand for treatments that could alleviate these burdens [oai_citation:3,Study reveals the economic burden for patients with vitiligo in the US is significant](https://medicalxpress.com/news/2024-01-reveals-economic-burden-patients-vitiligo.html).
In terms of treatment-seeking behavior, a notable proportion of patients do pursue various therapies despite the limited efficacy of current options. For instance, in the U.S., nearly half of the vitiligo patients received treatments such as corticosteroids and phototherapy within the first year of diagnosis. This suggests that if a more effective treatment were available, even more patients would be inclined to pursue it [oai_citation:4,Real-World Treatment Patterns in Patients with Vitiligo in the United States | Dermatology and Therapy](https://link.springer.com/article/10.1007/s13555-023-00983-3).
Additionally, the desire for effective treatments is underscored by the significant proportion of patients who report dissatisfaction with current treatment outcomes and the ongoing search for better solutions. Surveys have indicated that many patients are willing to invest in treatments that promise better cosmetic results and quality of life improvements [oai_citation:5,Patient Burden of Nonsegmental Vitiligo: A US Real-World Survey of Dermatologists and Their Patients | Dermatology and Therapy](https://link.springer.com/article/10.1007/s13555-024-01165-5) [oai_citation:6,Vitiligo Facts and Statistics: What You Need to Know](https://www.verywellhealth.com/vitiligo-5547792).
In summary, the psychological impact of vitiligo, combined with the significant economic burden and current treatment-seeking behavior, strongly suggests that an effective repigmentation treatment would be highly sought after and financially supported by vitiligo patients.
- Forums
- ASX - By Stock
- AVH
- ReCell Go Is Massive
ReCell Go Is Massive, page-79
-
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
|
|||||
Last
$2.66 |
Change
-0.060(2.21%) |
Mkt cap ! $184.2M |
Open | High | Low | Value | Volume |
$2.73 | $2.73 | $2.66 | $321.5K | 120.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1499 | $2.66 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.70 | 50 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1499 | 2.660 |
4 | 18148 | 2.650 |
1 | 11049 | 2.640 |
1 | 2000 | 2.630 |
2 | 10300 | 2.620 |
Price($) | Vol. | No. |
---|---|---|
2.700 | 50 | 1 |
2.710 | 325 | 1 |
2.750 | 265 | 1 |
2.770 | 1367 | 2 |
2.780 | 6884 | 2 |
Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online